Swiss National Bank Mimedx Group, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Swiss National Bank holds 231,300 shares of MDXG stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

231,300

Previous 231,300 -0.0%

Holding current value

$2.19 Million

Previous $1.6 Million 14.73%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$6.16 - $8.08 $14,784 - $19,392	2,400 Added 1.05%	231,300 $1.6 Million
Q4 2023 Feb 06, 2024	SELL	$5.7 - $9.14 $144,210 - $231,242	-25,300 Reduced 9.95%	228,900 $2.01 Million
Q3 2023 Nov 08, 2023	BUY	$6.35 - $8.16 $431,165 - $554,064	67,900 Added 36.45%	254,200 $1.85 Million
Q2 2023 Aug 09, 2023	BUY	$3.14 - $6.61 $84,466 - $177,809	26,900 Added 16.88%	186,300 $1.23 Million
Q1 2023 May 10, 2023	SELL	$2.97 - $4.81 $56,133 - $90,908	-18,900 Reduced 10.6%	159,400 $543,000
Q4 2022 Feb 08, 2023	BUY	$2.63 - $3.45 $15,517 - $20,355	5,900 Added 3.42%	178,300 $495,000
Q1 2022 May 09, 2022	BUY	$4.27 - $6.27 $55,509 - $81,510	13,000 Added 8.16%	172,400 $812,000
Q2 2021 Aug 06, 2021	BUY	$9.02 - $12.72 $1.44 Million - $2.03 Million	159,400 New	159,400 $1.99 Million
Q4 2018 Feb 13, 2019	SELL	$1.15 - $6.45 $209,299 - $1.17 Million	-182,000 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$10.87 - $13.9 $101,091 - $129,270	9,300 Added 5.39%	182,000 $2.3 Million
Q3 2017 Nov 03, 2017	BUY	$11.86 - $17.34 $2.05 Million - $2.99 Million	172,700	172,700 $2.05 Million

Others Institutions Holding MDXG

# of Institutions

208

Shares Held

98.1M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.08B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Mimedx Group, Inc. Transaction History